Zobrazeno 1 - 10
of 2 123
pro vyhledávání: '"ANTI-ANGIOGENIC THERAPY"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background The efficacy and safety of anti-angiogenic combination therapy in patients with driver gene-negative non-small cell lung cancer (NSCLC) with brain metastases (BM) are uncertain. Methods Eighty-eight records of driver gene-negative
Externí odkaz:
https://doaj.org/article/07b0f06d53e64d65a9dc00588a99a54d
Publikováno v:
Molecular Biomedicine, Vol 5, Iss 1, Pp 1-17 (2024)
Abstract The combination of anti-angiogenic drugs and immune checkpoint inhibitors (ICIs) in the treatment of tumors is emerging as a way to improve ICIs-resistant tumor therapy. In addition, gut microbes (GMs) are involved in angiogenesis in the tum
Externí odkaz:
https://doaj.org/article/bbf81cf0381a469caa7c04489c0eb4e1
Autor:
Qiao-xin Lin, Wen-wen Song, Wen-xia Xie, Yi-ting Deng, Yan-na Gong, Yi-ru Liu, Yi Tian, Wen-ya Zhao, Ling Tian, Dian-na Gu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 59, Iss , Pp 101077- (2025)
Objective: Anti-angiogenic therapy and immune checkpoint blockade therapy are currently important treatments for non-small cell lung cancer. However, the combined use of the two therapies is controversial, and few studies have investigated the effect
Externí odkaz:
https://doaj.org/article/74e44febb7d7493788a3bb40b1c0df5a
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The response rates to immunotherapy vary widely depending on the type of cancer and the specific treatment used and can be disappointingly low for many solid tumors. Fortunately, due to their complementary mechanisms of action, immunotherapy and anti
Externí odkaz:
https://doaj.org/article/98552d50336142c5a7ae54c3358bdbcb
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
In the management of advanced non-squamous non-small cell lung cancer (NSCLC) without driver gene mutations, the current therapeutic strategies encompass chemotherapy, chemotherapy combined with anti-angiogenic therapy, and chemotherapy combined with
Externí odkaz:
https://doaj.org/article/811b7ffcf7154db9916149264082ae4a
Publikováno v:
Zhongguo aizheng zazhi, Vol 34, Iss 7, Pp 659-668 (2024)
Background and purpose: There is a consensus within the medical community regarding the perioperative treatment of locally advanced gastric cancer (LAGC), yet the selection of an efficient and safe treatment strategy remains a contentious issue. Prev
Externí odkaz:
https://doaj.org/article/317e1f2cdb6f41729be815bada54356c
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 7383-7398 (2024)
Zhijie Jiang, Zhujun Fang, Dongsheng Hong, Xiaojuan Wang Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, People’s Republic of ChinaCorrespondence: Xiaojuan Wang, Email xiaoju
Externí odkaz:
https://doaj.org/article/c70fbdcc8f42470f8e8be771cc770a38
Autor:
Yan Ma, Ying Zhang, Hui-Ying Zhang, Ya Zhao, Xiu-Miao Li, Yi-Fei Jiang, Mu-Di Yao, Qin Jiang, Biao Yan
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Intravitreal injections of angiogenesis inhibitors have proved efficacious in the majority of patients with ocular angiogenesis. However, one-fourth of all treated patients fail to derive benefits from intravitreal injections. tRN
Externí odkaz:
https://doaj.org/article/2b8805e154834e67831c290b019d2461
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wu, Yilun a, b, Yuan, Xin a, b, Zhang, Yi a, b, Ma, Fang a, b, Zhao, Wei e, Sun, Xinrui a, b, Ma, Xue c, Chen, Yingjiao d, ⁎
Publikováno v:
In Biochemical and Biophysical Research Communications January 2025 742